Articles by Jean-Paul Viard

1 2 3 4 5

Vitamin D supplementation is associated with reduced immune activation levels in HIV-1-infected patients on suppressive antiretroviral therapy

Fabre-Mersseman, Véronique; Tubiana, Roland; Papagno, Laura; More

AIDS. 28(18):2677-2682, November 28th, 2014.

Changes in bone mineral density over a 2-year period in HIV-1-infected men under combined antiretroviral therapy with osteopenia

Assoumou, Lambert; Katlama, Christine; Viard, Jean-Paul; More

AIDS. 27(15):2425-2430, September 24th, 2013.

Effect of intermittent interleukin-2 therapy on CD4+ T-cell counts following antiretroviral cessation in patients with HIV

Lévy, Yves; Thiébaut, Rodolphe; Gougeon, Marie-Lise; More

AIDS. 26(6):711-720, March 27th, 2012.

Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study

Viard, Jean-Paul; Souberbielle, Jean-Claude; Kirk, Ole; More

AIDS. 25(10):1305-1315, June 19th, 2011.

Long-term immunovirologic control following antiretroviral therapy interruption in patients treated at the time of primary HIV-1 infection

Hocqueloux, Laurent; Prazuck, Thierry; Avettand-Fenoel, Véronique; More

AIDS. 24(10):1598-1601, June 19th, 2010.

Factors influencing peripheral blood mononuclear cell-associated HIV-1 DNA level after long-term suppressive antiretroviral therapy in 236 patients

Burgard, Marianne; Boufassa, Faroudy; Viard, Jean-Paul; More

AIDS. 23(16):2165-2171, October 23rd, 2009.

Acquired protein S deficiency leads to obliterative portal venopathy and to compensatory nodular regenerative hyperplasia in HIV-infected patients

Mallet, Vincent O; Varthaman, Aditi; Lasne, Dominique; More

AIDS. 23(12):1511-1518, July 31st, 2009.

Immunological success is predicted by enfuvirtide but not interleukin-2 therapy in immunodepressed patients

Viard, Jean-Paul; Fagard, Catherine; Chaix, Marie-Laure; More

AIDS. 23(11):1383-1388, July 17th, 2009.

Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score

Mocroft, Amanda; Ledergerber, Bruno; Zilmer, Kai; More

AIDS. 21(14):1867-1875, September 2007.

Long-term effects of intermittent interleukin-2 therapy in chronic HIV-infected patients (ANRS 048–079 Trials)*

Durier, Christine; Capitant, Catherine; Lascaux, Anne-Sophie; More

AIDS. 21(14):1887-1897, September 2007.

HIV-1 resistant strains acquired at the time of primary infection massively fuel the cellular reservoir and persist for lengthy periods of time

Ghosn, Jade; Pellegrin, Isabelle; Goujard, Cécile; More

AIDS. 20(2):159-170, January 9th, 2006.

Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy

Serpaggi, Jeanne; Chaix, Marie-Laure; Batisse, Dominique; More

AIDS. 20(2):233-240, January 9th, 2006.

Defective interleukin-2-dependent STAT5 signalling in CD8 T lymphocytes from HIV-positive patients: restoration by antiretroviral therapy

Kryworuchko, Marko; Pasquier, Virginie; Keller, Hélène; More

AIDS. 18(3):421-426, February 20th, 2004.

Evidence of genotypic resistance diversity of archived and circulating viral strains in blood and semen of pre-treated HIV-infected men

Ghosn, Jade; Viard, Jean-Paul; Katlama, Christine; More

AIDS. 18(3):447-457, February 20th, 2004.

Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA level

Viard, Jean-Paul; Burgard, Marianne; Hubert, Jean-Baptiste; More

AIDS. 18(1):45-49, January 2nd, 2004.

Clinical outcome among HIV-infected patients starting saquinavir hard gel compared to ritonavir or indinavir

Kirk, Ole; Mocroft, Amanda; Pradier, Christian; More

AIDS. 15(8):999-1008, May 25th, 2001.

1 2 3 4 5